The device is a single-patient-use stapler featuring 120 degrees of fully-wristed articulation, which Intuitive touts as “an industry first.”
Beyond the 60 mm device, Intuitive’s stapling portfolio includes 30 and 45 mm stapler instruments.
The stapler uses Intuitive’s SmartFire software to measure tissue compression before and during staple firing, automatically adjusting to the firing process as staples are formed, the company explained.
Surgeons control Intuitive’s latest stapler via the daVinci console – it’s compatible with the da Vinci Xi and X systems. The SureForm 60 device has general, thoracic, gynecologic, urologic and pediatric indications, according to Intuitive.
“Intuitive continues our minimally invasive innovation with our 60mm stapler, rooted in extensive research and development and an understanding of surgeons’ needs,” Sal Brogna, EVP & COO, said in prepared remarks.
ISRG shares were trading at $487.39 apiece in late afternoon activity today, up +0.4%.
Intuitive Surgical enjoyed a nearly two-decade monopoly in the robot-assisted surgery space. At DeviceTalks West, we'll delve into that history as longtime CEO Gary Guthart tells us how he got his start in medtech, how Intuitive came to enjoy such a commanding lead and what the future holds for medical robotics.
Use code GUTHART to save an additional 10%.